Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiaobenketamine Injection in Post-cardiac Surgery Heart Failure
CTR20150140Phase 2Active
- Sponsor
- Guangzhou Zhongwei Biotechnology
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of qiaobenketamine in heart failure (HF), cardioprotection, sponsored by Guangzhou Zhongwei Biotechnology. Started Mar 2015; status: active.
02
Drugs
qiaobenketamine
03
Conditions
heart failure (HF)cardioprotection
Beyond the preview
Go deeper on CTR20150140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150140.